US 12304964
CD38 modulating antibody
granted A61KA61K2039/505A61K2039/627
Quick answer
US patent 12304964 (CD38 modulating antibody) held by BLACK BELT THERAPEUTICS LIMITED expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BLACK BELT THERAPEUTICS LIMITED
- Grant date
- Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K2039/627, A61K39/395, A61P